HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toralf Melsom Selected Research

Glucose (Dextrose)

1/2018Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.
1/2016Prediabetes and Risk of Glomerular Hyperfiltration and Albuminuria in the General Nondiabetic Population: A Prospective Cohort Study.
7/2011Impaired fasting glucose is associated with renal hyperfiltration in the general population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toralf Melsom Research Topics

Disease

22Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 12/2010
12Kidney Diseases (Kidney Disease)
09/2023 - 12/2010
7Chronic Renal Insufficiency
01/2024 - 01/2015
5Albuminuria
12/2022 - 01/2016
4Hypertension (High Blood Pressure)
01/2024 - 12/2022
2Type 2 Diabetes Mellitus (MODY)
12/2022 - 01/2019
2Ischemic Stroke
11/2018 - 07/2012
2Diabetes Mellitus
01/2018 - 12/2010
1Hyperglycemia
09/2023
1Atherosclerosis
04/2023
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2022
1Solitary Kidney
12/2022
1Renal Insufficiency (Renal Failure)
10/2022
1Fibrosis (Cirrhosis)
01/2022
1Inflammation (Inflammations)
08/2021
1Humeral Fractures
01/2021
1Myocardial Infarction
11/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Isolated Systolic Hypertension
02/2017
1Obesity
11/2016
1Hyperuricemia
01/2016
1Prediabetic State (Prediabetes)
01/2016
1Insulin Resistance
01/2015
1Neoplasms (Cancer)
07/2012
1Hyperinsulinism (Hyperinsulinemia)
07/2011
1Stroke (Strokes)
12/2010

Drug/Important Bio-Agent (IBA)

20Iohexol (Omnipaque)FDA Link
01/2024 - 12/2010
13CreatinineIBA
01/2021 - 12/2010
7AlbuminsIBA
12/2022 - 01/2016
7Cystatin CIBA
01/2021 - 12/2010
3HDL CholesterolIBA
09/2023 - 01/2018
3Biomarkers (Surrogate Marker)IBA
12/2022 - 08/2017
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 07/2011
2Epidermal Growth Factor (EGF)IBA
02/2024 - 01/2021
2Triglycerides (Triacylglycerol)IBA
09/2023 - 01/2018
2Hexosaminidases (Hexosaminidase)IBA
12/2022 - 02/2016
2Orosomucoid (Seromucoid)IBA
12/2022 - 12/2022
1SodiumIBA
01/2024
1SaltsIBA
01/2024
1PotassiumIBA
01/2024
1HDL LipoproteinsIBA
09/2023
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2023
1Tec protein-tyrosine kinaseIBA
12/2022
1Iothalamic Acid (Iotalamic Acid)FDA Link
12/2022
1LigandsIBA
12/2022
1Endothelin-1 (Endothelin 1)IBA
12/2022
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2022
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2022
1Syndecan-4IBA
11/2018
1Syndecan-1 (Syndecan 1)IBA
11/2018
1RNA (Ribonucleic Acid)IBA
05/2018
18-Hydroxy-2'-DeoxyguanosineIBA
05/2018
18-hydroxyguanosineIBA
05/2018
1Antihypertensive Agents (Antihypertensives)IBA
02/2017
1Indicators and Reagents (Reagents)IBA
11/2016
1Appetite Depressants (Anorectics)IBA
10/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1AdiponectinIBA
01/2016
1symmetric dimethylarginineIBA
01/2015
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2015
1Arginine (L-Arginine)FDA Link
01/2015
1dimethylarginineIBA
01/2015

Therapy/Procedure

1Renal Replacement Therapy (Therapies, Renal Replacement)
10/2022